Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.95 EUR | -0.83% |
|
-0.83% | -9.09% |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.69 for the current period. Therefore, the company is undervalued.
- The company appears to be poorly valued given its net asset value.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 43.24 and 31.54 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.09% | 575M | - | ||
+0.54% | 101B | A- | ||
-11.50% | 59.17B | A- | ||
+73.33% | 48.2B | B | ||
+7.13% | 35.55B | B | ||
-0.46% | 30.82B | A- | ||
+2.40% | 18.43B | B- | ||
+18.96% | 17.68B | C+ | ||
+8.20% | 13.8B | B- | ||
-5.51% | 12.88B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 3101 Stock
- TO7 Stock
- Ratings Toyobo Co., Ltd.